Related Experiment Videos
[Systemic chemotherapy in metastatic colorectal adenocarcinomas]
Y Bécouarn1, R Brunet, A Ravaud
1Fondation Bergonié, Bordeaux.
Gastroenterologie Clinique Et Biologique
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Checkpoint inhibitors in metastatic papillary renal cell carcinoma.
Cancer treatment reviews·2021
Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.
Asia-Pacific journal of clinical oncology·2020
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
[Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010